Dose-dependent activation and deletion of antigen-specific T cells following oral tolerance

Annals of the New York Academy of Sciences

Volumn 778, Issue , 1996, Pages 111-121

  Chen, Youhai H ^a,b   Weiner, Howard L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; HELPER CELL; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PEYER PATCH; RAT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0029959955     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb21120.x     Document Type: Article

References (60)

1. WELLS, H. 1911. Studies on the chemistry of anaphylaxis. III. Experiments with isolated proteins, especially those of hen's egg. J. Infect. Dis. 9: 147-51.
2. CHASE, M. W. 1946. Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc. Soc. Exp. Biol. Med. 61: 257-59.
3. EMANOPATOR, S. N. & M. E. LAMM. 1988. Oral tolerance as a protective mechanism against hypersensitivity disease. Monogr. Allergy 24: 244-250.
4. MOWAT, A. M. 1987. The regulation of immune responses to dietary protein antigens. Immunol. Today 8: 93-8.
5. STROBEL, S. 1990. Mechanisms of gastrointestinal immunoregulation and food induced injury to the gut. Eur. J. Clin. Nutr. 45 (suppl. 1): 1-9.
6. STROBEL, S. 1990. Immunologically mediated damage to the intestinal mucosa. Acta Paediatr. Scand. (Suppl.) 365: 46-57.
7. JOHNSON, R. B., J. T. LABROOY & J. H. SKERRITT. 1990. Antibody responses reveal differences in oral tolerance to wheat and maize grain protein fractions. Clin. Exp. Immunol. 79(1): 135-40.
8. HIGGINS, P. & H. L. WEINER. 1988. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol. 140: 440-445.
9. BITAR, D. & C. C. WHITACRE. 1988. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell. Immunol. 112: 364-370.
10. NUSSENBLATT, R. B., R. R. CASPI, R. MAHDI et al. 1990. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J. Immunol. 144(5): 1689-1695.
11. SINGH, V. K., H. K. KALRA, K. YAMAKI & T. SHTNOHARA. 1992. Suppression of experimental autoimmune uveitis in rats by the oral administration of the uveitopathogenic S-antigen fragment and a cross-reactive homologous peptide. Cell. Immunol. 139(1): 81-90.
12. THOMPSON, H. & N. STAINES. 1986. Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin. Exp. Immunol. 64: 581-86.
13. NAGLER-ANDERSON, C., L. A. BOBER, M. E. ROBINSON, G. W. SISKIND & F. J. THORBEKE. 1986. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc. Natl. Acad. Sci. USA 83: 7443-7446.
14. ZHANG, Z. Y., C. S. LEE, O. LIDER & H. L. WEINER. 1990. Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J. Immunol. 145(8): 2489-93.
15. ZHANG, J., L. DAVIDSON, G. EISENBARTH & H. WEINER. 1991. Suppression of diabetes in NOD mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. USA 88: 10252-56.
16. + T cells that suppress adoptive transfer of diabetes. J. Autoimmunity 7: 655-63.
17. WEINER, H., A. FRIEDMAN, F. MILLER et al. 1994. Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12: 809-837.
18. WEINER, H. L., G. A. MACKIN, M. MATSUI et al. 1993. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259: 1321-24.
19. TRENTHAM, D., R. DYNESIUS-TRENTHAM, E. ORAV et al. 1993. Effects of oral administration of collagen on rheumatoid arthritis. Science 261: 1727.
20. TOMASI, T. JR. 1980. Oral tolerance. [Review]. Transplantation 29(5): 353-6.
21. MOWAT, A. M., S. STROBEL, H. E. DRUMMOND & A. FERGUSON. 1982. Immunological responses to fed protein antigens in mice. I. Reversal of oral tolerance to ovalbumin by cyclophosphamide. Immunology 45(1): 105-13.
22. WEINER, H., A. FRIEDMAN, F. MILLER et al. 1994. Oral tolerance: Immunologic mechanisms and treatment of murine and human organ specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12: 809-837.
23. WHITACRE, C. C., I. E. GIENAPP, C. G. OROSZ & D. M. BITAR. 1991. Oral tolerance in experimental autoimmune encephalitomyelitis. III. Evidence for clonal anergy. J. Immunol. 147(7): 2155-63.
24. MELAMED, D. & A. FRIEDMAN. 1993. Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur. J. Immunol. 23(4): 935-42.
25. MELAMED, D. & A. FRIEDMAN. 1993. Modification of the immune response by oral tolerance: antigen requirements and interaction with immunogenic stimuli. Cell. Immunol. 146: 412-420.
26. JENKINS, M., C. CHEN, G. JUNG, D. MUELLER & R. SCHWARTZ. 1990. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J. Immunol. 144(1): 16-24.
27. SCHWARTZ, R. H. 1990. A cell culture model for T lymphocyte clonal anergy. Science 248: 1349-1356.
28. GREGERSON, D. S., W. F. OBRITSCH & L. A. DONOSO. 1993. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low versus high dose feeding protocols. J. Immunol. 151(10): 5751-61.
29. FRIEDMAN, A. & H. WEINER. 1994. Induction of anergy or active suppression following oral tolerance is determined by frequency of feeding and antigen dosage. Proc. Natl. Acad. Sci. USA 91: 6688.
30. LAMONT, A. G., A. M. MOWAT, M. J. BROWNING & D. M. PARROTT. 1988. Genetic control of oral tolerance to ovalbumin in mice. Immunology 63(4): 737-739.
31. MILLER, A., O. LIDER, A. AL-SABBAGH & H. WEINER. 1992. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. V. Hierarchy of suppression by myelin basic protein from different species. J. Neuroimmunol. 39: 243-250.
32. KHOURY, S. J., O. LIDER, A. AL-SABBAGH & H. L. WEINER. 1990. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide. Cell. Immunol. 131: 302-310.
33. REVILLARD, J. P., G. COZON & C. CZERKINSKY. 1992. Oral administration of immunomodulators and the mucosal immune system. Dev. Biol. Stand. 77: 31-7.
34. PIERRE, P., O. DENIS, H. BAZIN, E. MBONGOLO MBELLA & J. P. VAERMAN. 1992. Modulation of oral tolerance to ovalbumin by cholera toxin. Eur. J. Immunol. 22(12): 3179-82.
35. BURNS, D., M. SCOTT, I. PHILLIPS & S. BROD. 1993. Oral administration of type I interferons prevents sensitization to MBP in acute EAE. J. Immunol. 150(8,II): 1111A.
36. SUN, J.-B., C. HOLMGREN & C. CZERKINSKY. 1994. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Natl. Acad. Sci. USA 91: 10795-9.
37. MILLER, A., O. LIDER & H. L. WEINER. 1991. Antigen-driven bystander suppression following oral administration of antigens. J. Exp. Med. 174: 791-798.
38. SANTOS, L., A. AL-SABBAGH, A. LONDONO & H. WEINER. 1994. Oral tolerance to myelin basic protein induces TGF-β secreting T cells in Peyer's patches. Cell. Immunol. 157: 439-447.
39. YOSHINO, S., E. QUATTROCCI & H. WEINER. 1995. Arthritis Rheum. In press.
40. CHEN, Y., V. K. KUCHROO, J.-I. INOBE, D. A. HAFLER & H. L. WEINER. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265: 1237-1240.
41. STROBEL, S., A. M. MOWAT, H. E. DRUMMOND, M. G. PICKERING & A. FERGUSON. 1983. Immunological responses to fed protein antigens in mice. II. Oral tolerance for CMI is due to activation of cyclophosphamide-sensitive cells by gut-processed antigen. Immunology 49(3): 451-6.
42. MICHALEK, S. M., J. R. MCGHEE, H. KIYONO, D. E. COLWELL, J. H. ELDRIDGE, M. J. WANNEMUEHLER & W. J. KOOPMAN. 1983. The IgA response: Inductive aspects, regulatory cells, and effector functions. Ann. N.Y. Acad. Sci. 409: 48-71.
43. MATTHEWS, J. B., B. H. FIVAZ & H. F. SEWELL. 1981. Serum and salivary antibody responses and the development of oral tolerance after oral and intragastric antigen administration. Int. Arch. Allergy Appl. Immunol. 65(1): 107-113.
44. SILVERMAN, G. A., B. A. PERI & R. M. ROTHBERG. 1982. Systemic antibody responses of different species following ingestion of soluble protein antigens. Dev. Comp. Immunol. 6(4): 737-746.
45. MILLER, A., O. LIDER, A. B. ROBERTS, M. B. SPORN & H. L. WEINER. 1992. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of TGFβ following antigen specific triggering. Proc. Natl. Acad. Sci. USA 89: 421-425.
46. AL-SABBAGH, A., A. MILLER, L. M. B. SANTOS & H. L. WEINER. 1994. Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid induced experimental autoimmune encephalomyelitis in the SJL mouse. Eur. J. Immunol. 24: 2104-9.
47. JALKENEN, S. 1990. Lymphocyte homing to the gut. Springer Semin. Immunopathology 12: 153-164.
48. MOWAT, A. M. 1990. Human intraepithelial lymphocytes. Springer Semin. Immunopathology 12: 165-190.
49. + lymphocyte populations with different T cell receptors: a role for the gut epithelium in T cell differentiation. J. Exp. Med 173: 471-481.
50. SANTOS, L., O. LIDER, J. AUDETTE, S. KHOURY & H. WEINER. 1990. Characterization of immunomodulatory properties and accessory cell function of small intestinal epithelial cells. Cell. Immunol. 127: 26-34.
51. CHEN, Y., J.-I. INOBE & H. L. WEINER. 1995. Induction of oral tolerance to MBP in CD8-depleted mice: both CD4 and CD8 cells mediate the active suppression component of oral tolerance. J. Immunol. 155: 910-916.
52. 2 cells in murine Peyer's patches by oral immunization. Int. Immunol. 4(4): 433-445.
53. ZAMVIL, S. S. & L. STEINMAN. 1990. The T lymnphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8: 579-621.
54. SALGAME, P., J. ABRAMS, C. CLAYBERGER, H. GOLDSTEIN, J. CONVIT & R. MODLIN. 1991. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254: 279-82.
55. + suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor beta. J. Immunol. 146: 1163-68.
56. ROBERTS, A. & M. SPORN. 1993. Physiological actions and clinical applications of transforming growth factor beta (TGFb). Growth Factors 8(1): 1-9.
57. WAHL, S. 1992. Transforming growth factor beta (TGFb) in inflammation: a cause and a cure. J. Clin. Immunol. 12: 61-74.
58. KIM, P.-H. & M. F. KAGNOFF. 1990. Transforming growth factor-β1 is a costimulatory for IgA production. J. Immunol. 144: 3411-3416.
59. MOSMANN, T. & R. COFFMAN. 1989. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv. Immunol. 46: 111-47.
60. CHEN, Y., J.-I. INOBE, R. MARKS, P. GONNELLA, V. K. KUCHROO & H. L. WEINER. 1995. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376: 177-180.